Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Karnataka has launched India's first state-led Centre of Excellence for Space Technology (CoE SpaceTech Foundation) in Bengaluru. This init...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

The Karnataka Bioeconomy Report 2025, released by the state's IT/BT ministry, in collaboration with the Association of Biotechnology Led En...

In 2024, South India led India's bioeconomy, contributing 45.4% ($75.2 billion), with Maharashtra, Karnataka, and Telangana emerging as key...

P M Murali, Managing Director and CEO, Evolva Biotech, was re-elected as President for a second term at the meet here last week, an ABLE re...

It needs only to address some fundamental areas of policy and regulation, and take steps towards creating an environment that encourages, n...

After India allowed planting of Bt Cotton in 2002, it transformed from being an importer of cotton in 2002, to the second largest exporter ...

As per the Union budget 2014, these services, which were previously exempt, would now attract service tax of 12.36 per cent.

To provide affordable healthcare with innovative medicines, India needs an investment of Rs 30,000 cr annually in next 5 years, say industr...

Considering biotechnology to be area of focus in improving farm productivity, Union Minister of State for Agriculture Tariq Anwar said ther...

ABLE and BIRAC have signed an agreement to facilitate technical knowledge and exchange information on the biotech industry.

PM Murali, President, Association of Biotechnology Led Enterprises (ABLE) says the Union Budget for 2013-14 is not encouraging for the biot...

Industry body for agri-biotech sector ABLE today asked the government to remove the moratorium on commercial cultivation of Bt brinjal.

ABLE, WBBA signed an MoU for broad ranging cooperation to support "breakthrough" discoveries in healthcare, agri and clean energy sector.

Two years after announcing a JV with Mylan, Biocon has revealed the potential of its drugs under the biologics deal with Mylan.

Department of biotechnology's latest initiative BIPP could provide a fillip for research, more so in light of industry facing a credit sque...